+ All Categories
Home > Documents > Oriflame Investors Presentation Q1 2010

Oriflame Investors Presentation Q1 2010

Date post: 28-Oct-2014
Category:
Upload: hangal-sok
View: 29 times
Download: 7 times
Share this document with a friend
Popular Tags:
15
22-06-06 Copyright ©2010 by Oriflame Cosmetics SA Oriflame Cosmetics First Quarter 2010 Investor Presentation Magnus Brännström, CEO Gabriel Bennet, CFO Patrik Linzenbold, IR Dir.
Transcript
Page 1: Oriflame Investors Presentation Q1 2010

23-04-07 Copyright ©2010 by Oriflame Cosmetics SA

Oriflame Cosmetics First Quarter 2010Investor Presentation

Magnus Brännström, CEOGabriel Bennet, CFOPatrik Linzenbold, IR Dir.

Page 2: Oriflame Investors Presentation Q1 2010

Financial Highlights

Sales +6% to €361.9m (€341.3m)

• +4% in local currency

• Favourable currency development.

Operating profit: €42.2m (€37.9m)

• Operating margin: 11.7% (11.1%).

Net profit at €37.2m (€24.2m).

Operating cash flow: €20.7m (€12.6m).

2Copyright ©2010 by Oriflame Cosmetics SA

Page 3: Oriflame Investors Presentation Q1 2010

Operational Highlights

Challenging start of the year • Sales force development below

expectations– Average sales force: +12%

– Closing sales force: +6% to 3.5m

• Tough comparables and negative timing effect

• Low service levels

• Weak productivity– -8% in local currency.

Product marketing• Units: -4%, prices: +3%, product mix:

+6%• Strong launches of higher priced products:

– Fragrances: +14%

– Accessories: +18%.

23-04-07 Copyright ©2010 by Oriflame Cosmetics SA 3

Page 4: Oriflame Investors Presentation Q1 2010

150

200

250

300

350

400

450

500

550

600

650

700

750

800

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1

10%

15%

20%

25%

30%

Sales LTM Op Margin LTM€m

2008 2009 ´10

CIS & BalticsQ1 ’10 Q1 ’09 Change

Sales, € 205.1 196.9 4%

Lc sales - - 3%

Operating profit, € 31.3 33.6 (7%)

Operating margin 15.3% 17.1% -

Sales force, avg. 2,081 1,831 14%

Sales force and productivity• Closing sales force +6%• Lc productivity -11%• € productivity -8%• Negative catalogue timing

effect.

Sales growth was particularly strong in Ukraine and Moldova. Sales in Russia was constant.

Lower gross margins• Negative timing effects on

purchases of inventory• Negative product mix effect• Partly offset by price increases.

23-04-07 Copyright ©2010 by Oriflame Cosmetics SA 4

Page 5: Oriflame Investors Presentation Q1 2010

100

125

150

175

200

225

250

275

300

325

350

375

400

425

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1

10%

15%

20%

25%

30%

Sales LTM Op Margin LTM€m

20092008 ´10

EMEAQ1 ’10 Q1 ’09 Change

Sales, € 98.3 97.1 1%

Lc sales - - (3%)

Operating profit, €

10.7 13.3 (20%)

Operating margin 10.9% 13.7% -

Sales force, avg. 813 751 8%

Sales force and productivity• Closing sales force +3%• Lc productivity –11%• € productivity -6%.

Strong sales growth in Turkey, Morocco and Egypt while weak in most Central European markets

• Negative catalogue timing effects

• Very tough macro economic environment in many countries.

Operating margin decrease• Negative product mix effect• Sales enhancing initiatives.

23-04-07 Copyright ©2010 by Oriflame Cosmetics SA 5

Page 6: Oriflame Investors Presentation Q1 2010

0

10

20

30

40

50

60

70

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1

0%

5%

10%

15%

20%

Sales LTM Op Margin LTM€m

20092008 ´10

Latin AmericaQ1 ’10 Q1 ’09 Change

Sales, € 17.4 14.6 19%

Lc sales - - 10%

Operating profit, €

0.4 (0.6) Nm

Operating margin 2.4% (3.9%) -

Avg. sales force 137 124 10%

Sales force and productivity

• Closing sales force +14%• Lc productivity +0%• € productivity +8%.

Strong sales growth particularly in Mexico and Colombia.

Margin improvement mainly due to positive currency effects.

23-04-07 Copyright ©2010 by Oriflame Cosmetics SA 6

Page 7: Oriflame Investors Presentation Q1 2010

0

10

20

30

40

50

60

70

80

90

100

110

120

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1

-5%

0%

5%

10%

15%

Sales LTM Op Margin LTM€m

20092008 ´10

AsiaQ1 ’10 Q1 ’09 Change

Sales, € 36.3 26.3 38%

Lc sales - - 35%

Operating profit, € 1.2 1.2 -

Operating margin 3.4% 4.4% -

Avg. sales force 466 418 12%

Strong sales• Closing sales force +7%• Lc productivity +23%• € productivity +24%.

Strong sales development in most markets.

Operating profit constant at €1.2m.

23-04-07 Copyright ©2010 by Oriflame Cosmetics SA 7

Page 8: Oriflame Investors Presentation Q1 2010

Q1 - Income Statement Highlights Q1 ’10 Q1 ’09 Change

Sales, € 361.9 341.3 6%

Gross margin 67.0% 66.3% -

EBITDA, € 49.3 43.3 14%

Operating profit, € 42.2 37.9 11%

Operating margin 11.7% 11.1% -

700

750

800

850

900

950

1000

1050

1100

1150

1200

1250

1300

1350

1400

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1

0%

2%

4%

6%

8%

10%

12%

14%

16%

18%

20%

Sales LTM Op Margin LTM€m

2008 2009 2010

Local currency sales +4%.

Unit sales -4%.

Gross margin 67.0% (66.3%).

Operating margin 11.7% (11.1%).

Net profit €37.2m (€24.2m).

23-04-07 Copyright ©2010 by Oriflame Cosmetics SA 8

Page 9: Oriflame Investors Presentation Q1 2010

Consolidated Statement of Financial Position Highlights

Net debt: €155.8m (€193.0m).

Net debt / EBITDA: 0.87 (0.91).

Interest cover: 7.2 (7.9).

Oriflame completed a $165m issue of private placement notes after the close of the period.

23-04-07 Copyright ©2010 by Oriflame Cosmetics SA 9

0

50

100

150

200

250

300

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1

0,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

1,8

2,0

Net debt Net debt/EBITDA€m

2008 2009 '10

0

40

80

120

160

200

240

280

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1

Total inventory€m

2008 2009 '10

Page 10: Oriflame Investors Presentation Q1 2010

Cash Flow Statement Highlights

Q1 operating cash flow €20.7m (€12.6m), a result of:

• EBITDA €49.3m (€43.3m)• Increase of working capital:

€-21.9m (€-19.4) • Interest and taxes €-9.5m

(€-11.9m).

Cash flow used in investing activities: €-19.1m (€-8.6m).

Cash flow Q1 ’10 Q1 ’09

EBITDA 49.3 43.3

∆ Working Capital

-21.9 -19.4

Operating CF 20.7 12.6

CF Investing Activities

-19.1 -8.6

1023-04-07 Copyright ©2010 by Oriflame Cosmetics SA

0

25

50

75

100

125

150

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1

Op cash flow (LTM) Capex (LTM)€m

20092008 '10

Page 11: Oriflame Investors Presentation Q1 2010

11

Quarterly Variations

-6%

-2%

2%

6%

10%

14%

18%

22%

26%

30%

34%

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1

Sales growth, Y/Y in Euro Sales growth, Y/Y in local currency

2006 20092007 2008 ´10

A number of factors impact sales and margins in-between quarters:

Effectiveness of individual catalogues and product introductions Effectiveness and timing of recruitment programmes Timing of sales and marketing activities The number of effective sales days per quarter Currency effect on sales and results.

23-04-07 Copyright ©2010 by Oriflame Cosmetics SA

Page 12: Oriflame Investors Presentation Q1 2010

Group Currency Impact 2008-Group Currency Impact 2008-20102010

1223-04-07 Copyright ©2010 by Oriflame Cosmetics SA

Page 13: Oriflame Investors Presentation Q1 2010

Conclusion

Challenging start of the year• Lower sales force growth• Tough comparables and negative timing

effects at the start of this year• Service levels• Negative productivity.

Focus areas• Attractiveness of Oriflame opportunity

drives recruitment • Leadership development• Improved service levels• Price and product communication• Confident to reach our full year outlook.

1323-04-07 Copyright ©2010 by Oriflame Cosmetics SA

Page 14: Oriflame Investors Presentation Q1 2010

Long Term Targets and Outlook

Outlook 2010:• Sales growth of around 10% in local

currency.• Operating margin of above 12% at

current exchange rates.

Long term targets:• Local currency sales growth of around

10% per annum.• Operating margin of 15%.

1423-04-07 Copyright ©2010 by Oriflame Cosmetics SA

Page 15: Oriflame Investors Presentation Q1 2010

23-04-07 Copyright ©2010 by Oriflame Cosmetics SA 15


Recommended